Top Key Companies for AI In Vitro Diagnostic Market: Renalytix, Seegene, Sysmex, PathAI, Prognos, Qiagen, CloudMedX Health, Deepcell, Digital Diagnostics, EKF Diagnostics Holdings, Freenome, GE Healthcare, Glooko, Adaptive Biotechnologies, Aidoc, Anumana, ARUP Laboratories, K Health, Lunit.
Global AI In Vitro Diagnostic Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2025-2032, Considering the Base Year As 2024.
Global AI In Vitro Diagnostic Market Overview And Scope:
The Global AI In Vitro Diagnostic Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of AI In Vitro Diagnostic utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2025 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Global AI In Vitro Diagnostic Market Segmentation
By Type, AI In Vitro Diagnostic market has been segmented into:
Next-Generation Sequencing Technology
PCR Technology
Chemistry and IA Technology
Pathology Technology
By Application, AI In Vitro Diagnostic market has been segmented into:
Cancer Diagnostics
Infectious Disease Testing
Metabolic Testing
Cardiac Testing
Diabetes Testing
Regional Analysis of AI In Vitro Diagnostic Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of AI In Vitro Diagnostic Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The AI In Vitro Diagnostic market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the AI In Vitro Diagnostic market.
Top Key Companies Covered in AI In Vitro Diagnostic market are:
Renalytix
Seegene
Sysmex
PathAI
Prognos
Qiagen
CloudMedX Health
Deepcell
Digital Diagnostics
EKF Diagnostics Holdings
Freenome
GE Healthcare
Glooko
Adaptive Biotechnologies
Aidoc
Anumana
ARUP Laboratories
K Health
Lunit
Key Questions answered in the AI In Vitro Diagnostic Market Report:
1. What is the expected AI In Vitro Diagnostic Market size during the forecast period, 2025-2032?
2. Which region is the largest market for the AI In Vitro Diagnostic Market?
3. What is the expected future scenario and the revenue generated by different regions and countries in the AI In Vitro Diagnostic Market, such as North America, Europe, AsiaPacific & Japan, China, U.K., South America, and Middle East and Africa?
4. What is the competitive strength of the key players in the AI In Vitro Diagnostic Market on the basis of the analysis of their recent developments, product offerings, and regional presence?
5. Where do the key AI In Vitro Diagnostic companies lie in their competitive benchmarking compared to the factors of market coverage and market potential?
6. How are the adoption scenario, related opportunities, and challenges impacting the AI In Vitro Diagnostic Markets?
7. How is the funding and investment landscape in the AI In Vitro Diagnostic Market?
8. Which are the leading consortiums and associations in the AI In Vitro Diagnostic Market, and what is their role in the market?
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: AI In Vitro Diagnostic Market by Type
5.1 AI In Vitro Diagnostic Market Overview Snapshot and Growth Engine
5.2 AI In Vitro Diagnostic Market Overview
5.3 Next-Generation Sequencing Technology
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Next-Generation Sequencing Technology: Geographic Segmentation
5.4 PCR Technology
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 PCR Technology: Geographic Segmentation
5.5 Chemistry and IA Technology
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Chemistry and IA Technology: Geographic Segmentation
5.6 Pathology Technology
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Pathology Technology: Geographic Segmentation
Chapter 6: AI In Vitro Diagnostic Market by Application
6.1 AI In Vitro Diagnostic Market Overview Snapshot and Growth Engine
6.2 AI In Vitro Diagnostic Market Overview
6.3 Cancer Diagnostics
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Cancer Diagnostics: Geographic Segmentation
6.4 Infectious Disease Testing
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Infectious Disease Testing: Geographic Segmentation
6.5 Metabolic Testing
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Metabolic Testing: Geographic Segmentation
6.6 Cardiac Testing
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2017-2032F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Cardiac Testing: Geographic Segmentation
6.7 Diabetes Testing
6.7.1 Introduction and Market Overview
6.7.2 Historic and Forecasted Market Size (2017-2032F)
6.7.3 Key Market Trends, Growth Factors and Opportunities
6.7.4 Diabetes Testing: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 AI In Vitro Diagnostic Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 AI In Vitro Diagnostic Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 AI In Vitro Diagnostic Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 RENALYTIX
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 SEEGENE
7.4 SYSMEX
7.5 PATHAI
7.6 PROGNOS
7.7 QIAGEN
7.8 CLOUDMEDX HEALTH
7.9 DEEPCELL
7.10 DIGITAL DIAGNOSTICS
7.11 EKF DIAGNOSTICS HOLDINGS
7.12 FREENOME
7.13 GE HEALTHCARE
7.14 GLOOKO
7.15 ADAPTIVE BIOTECHNOLOGIES
7.16 AIDOC
7.17 ANUMANA
7.18 ARUP LABORATORIES
7.19 K HEALTH
7.20 LUNIT
Chapter 8: Global AI In Vitro Diagnostic Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Next-Generation Sequencing Technology
8.2.2 PCR Technology
8.2.3 Chemistry and IA Technology
8.2.4 Pathology Technology
8.3 Historic and Forecasted Market Size By Application
8.3.1 Cancer Diagnostics
8.3.2 Infectious Disease Testing
8.3.3 Metabolic Testing
8.3.4 Cardiac Testing
8.3.5 Diabetes Testing
Chapter 9: North America AI In Vitro Diagnostic Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Next-Generation Sequencing Technology
9.4.2 PCR Technology
9.4.3 Chemistry and IA Technology
9.4.4 Pathology Technology
9.5 Historic and Forecasted Market Size By Application
9.5.1 Cancer Diagnostics
9.5.2 Infectious Disease Testing
9.5.3 Metabolic Testing
9.5.4 Cardiac Testing
9.5.5 Diabetes Testing
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe AI In Vitro Diagnostic Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Next-Generation Sequencing Technology
10.4.2 PCR Technology
10.4.3 Chemistry and IA Technology
10.4.4 Pathology Technology
10.5 Historic and Forecasted Market Size By Application
10.5.1 Cancer Diagnostics
10.5.2 Infectious Disease Testing
10.5.3 Metabolic Testing
10.5.4 Cardiac Testing
10.5.5 Diabetes Testing
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe AI In Vitro Diagnostic Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Next-Generation Sequencing Technology
11.4.2 PCR Technology
11.4.3 Chemistry and IA Technology
11.4.4 Pathology Technology
11.5 Historic and Forecasted Market Size By Application
11.5.1 Cancer Diagnostics
11.5.2 Infectious Disease Testing
11.5.3 Metabolic Testing
11.5.4 Cardiac Testing
11.5.5 Diabetes Testing
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific AI In Vitro Diagnostic Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Next-Generation Sequencing Technology
12.4.2 PCR Technology
12.4.3 Chemistry and IA Technology
12.4.4 Pathology Technology
12.5 Historic and Forecasted Market Size By Application
12.5.1 Cancer Diagnostics
12.5.2 Infectious Disease Testing
12.5.3 Metabolic Testing
12.5.4 Cardiac Testing
12.5.5 Diabetes Testing
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa AI In Vitro Diagnostic Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Next-Generation Sequencing Technology
13.4.2 PCR Technology
13.4.3 Chemistry and IA Technology
13.4.4 Pathology Technology
13.5 Historic and Forecasted Market Size By Application
13.5.1 Cancer Diagnostics
13.5.2 Infectious Disease Testing
13.5.3 Metabolic Testing
13.5.4 Cardiac Testing
13.5.5 Diabetes Testing
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America AI In Vitro Diagnostic Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Next-Generation Sequencing Technology
14.4.2 PCR Technology
14.4.3 Chemistry and IA Technology
14.4.4 Pathology Technology
14.5 Historic and Forecasted Market Size By Application
14.5.1 Cancer Diagnostics
14.5.2 Infectious Disease Testing
14.5.3 Metabolic Testing
14.5.4 Cardiac Testing
14.5.5 Diabetes Testing
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
AI In Vitro Diagnostic Scope:
|
Report Data
|
AI In Vitro Diagnostic Market
|
|
AI In Vitro Diagnostic Market Size in 2025
|
USD XX million
|
|
AI In Vitro Diagnostic CAGR 2025 - 2032
|
XX%
|
|
AI In Vitro Diagnostic Base Year
|
2024
|
|
AI In Vitro Diagnostic Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Renalytix, Seegene, Sysmex, PathAI, Prognos, Qiagen, CloudMedX Health, Deepcell, Digital Diagnostics, EKF Diagnostics Holdings, Freenome, GE Healthcare, Glooko, Adaptive Biotechnologies, Aidoc, Anumana, ARUP Laboratories, K Health, Lunit.
|
|
Key Segments
|
By Type
Next-Generation Sequencing Technology
PCR Technology
Chemistry and IA Technology
Pathology Technology
By Applications
Cancer Diagnostics
Infectious Disease Testing
Metabolic Testing
Cardiac Testing
Diabetes Testing
|
